nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—CYP2J2—Fatty acids—CYP2A7—nicotine dependence	0.123	0.189	CbGpPWpGaD
Masoprocol—CYP2J2—Xenobiotics—CYP2A7—nicotine dependence	0.0977	0.15	CbGpPWpGaD
Masoprocol—IGF1R—cardiovascular system—nicotine dependence	0.071	0.217	CbGeAlD
Masoprocol—CYP2J2—cardiovascular system—nicotine dependence	0.0482	0.147	CbGeAlD
Masoprocol—LTB4R—brain—nicotine dependence	0.0422	0.129	CbGeAlD
Masoprocol—CYP2J2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0406	0.0622	CbGpPWpGaD
Masoprocol—CYP2J2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.04	0.0614	CbGpPWpGaD
Masoprocol—ALOX5—cardiovascular system—nicotine dependence	0.0379	0.116	CbGeAlD
Masoprocol—CYP2J2—midbrain—nicotine dependence	0.0376	0.115	CbGeAlD
Masoprocol—IGF1R—brain—nicotine dependence	0.0349	0.107	CbGeAlD
Masoprocol—CYP2J2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0329	0.0504	CbGpPWpGaD
Masoprocol—CYP2J2—brain—nicotine dependence	0.0236	0.0723	CbGeAlD
Masoprocol—LTB4R—GPCR ligand binding—TAS2R16—nicotine dependence	0.0205	0.0314	CbGpPWpGaD
Masoprocol—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0186	0.0286	CbGpPWpGaD
Masoprocol—ALOX5—brain—nicotine dependence	0.0186	0.0569	CbGeAlD
Masoprocol—CYP2J2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0185	0.0284	CbGpPWpGaD
Masoprocol—CYP19A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0184	0.0282	CbGpPWpGaD
Masoprocol—CYP2J2—Biological oxidations—CYP2A7—nicotine dependence	0.0175	0.0268	CbGpPWpGaD
Masoprocol—CYP2J2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0172	0.0264	CbGpPWpGaD
Masoprocol—CYP19A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0151	0.0232	CbGpPWpGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.0132	0.0203	CbGpPWpGaD
Masoprocol—CYP19A1—brain—nicotine dependence	0.0129	0.0394	CbGeAlD
Masoprocol—LTB4R—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0116	0.0178	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.0113	0.0174	CbGpPWpGaD
Masoprocol—L-DOPA—DRD2—nicotine dependence	0.0108	0.518	CrCbGaD
Masoprocol—LTB4R—Signaling by GPCR—TAS2R16—nicotine dependence	0.0105	0.0161	CbGpPWpGaD
Masoprocol—Dopamine—DRD2—nicotine dependence	0.01	0.482	CrCbGaD
Masoprocol—LTB4R—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00957	0.0147	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—FGD1—nicotine dependence	0.00909	0.0139	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—OPRM1—nicotine dependence	0.00864	0.0132	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00851	0.0131	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—FGD1—nicotine dependence	0.00825	0.0127	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.0082	0.0126	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—CYP2A7—nicotine dependence	0.00802	0.0123	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00791	0.0121	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—DRD2—nicotine dependence	0.00625	0.00958	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TAS2R16—nicotine dependence	0.00621	0.00953	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TAS2R16—nicotine dependence	0.00528	0.0081	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—OPRM1—nicotine dependence	0.00488	0.00749	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FGD1—nicotine dependence	0.00488	0.00748	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—OPRM1—nicotine dependence	0.00443	0.0068	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AKR1B10—nicotine dependence	0.00431	0.0066	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FGD1—nicotine dependence	0.00415	0.00636	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AKR1B10—nicotine dependence	0.00366	0.00561	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—DRD2—nicotine dependence	0.00353	0.00541	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—DRD2—nicotine dependence	0.00321	0.00492	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—WASF2—nicotine dependence	0.00303	0.00465	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP2A7—nicotine dependence	0.00299	0.00458	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—WASF1—nicotine dependence	0.00291	0.00446	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP2A7—nicotine dependence	0.00266	0.00408	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—OPRM1—nicotine dependence	0.00262	0.00402	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—WASF2—nicotine dependence	0.00258	0.00396	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—WASF1—nicotine dependence	0.00247	0.00379	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—OPRM1—nicotine dependence	0.00223	0.00341	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—DRD2—nicotine dependence	0.00189	0.0029	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—DRD2—nicotine dependence	0.00161	0.00247	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP2A7—nicotine dependence	0.00137	0.0021	CbGpPWpGaD
